News Focus
News Focus
Followers 249
Posts 15657
Boards Moderated 1
Alias Born 08/14/2003

Re: Kaizenman post# 356474

Saturday, 02/20/2021 2:13:55 PM

Saturday, February 20, 2021 2:13:55 PM

Post# of 820791
Let's be fair to BP, they have worldwide distribution and sales forces that can add our vaccines to what they currently offer. I don't expect them to make the vaccine, but they can provide the resources needed to support it's use around the world. Clearly they can support the preparation of the BLA as well as designing and funding additional trials of both DCVax's.

It's not that NWBO cannot do the job without them, they can, but it will be faster, and easier to do with them, and perhaps most importantly they'll provide the funding needed to get new trials started rapidly without massive dilution by the company.

I still believe that DCVax-Direct could be substantially bigger than DCVax-L but the only way to prove it is a substantial size clinical tria

l that incorporates many solid tumors. I believe it's use will prove of benefit prior to surgery in patients with operable tumors in addition to patients with inoperable tumors, but naturally we'll deal with inoperable tumors first.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News